Codes ATC:
L01XX24
EMLc
Indication
Lymphoid leukaemia, not elsewhere classified
Code ICD11:
2C03.3
INN
Pegaspargase
Type de médicament
Biological agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Additional notes
Including quality-assured biosimilars
Formulations
Parenteral > General injections > IV:
3750 units per 5 mL in vial ;
3750 units in vial powder for injection
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the addition of pegaspargase powder for injection 3750 units in vial to the EML and EMLc.